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membrane damage) or are we dealing with a new proton transporter
was open. In this work, TCP-C15 was shown to slowly incorporate
into membrane. Therefore, by long incubation (10–20 min) we
showed an authentic uncoupling effect (stimulation of mitochondrial
respiration) with nanomolar concentrations of this compound. With
the help of a new experimental method, it was shown that the
mitotropic compound of SkQ set, which in reductive conditions in the
mitochondrion transforms into the hydroquinone form, shows
uncoupling effect at nanomolar concentrations.
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Mitochondrial outer-membrane permeabilization (MOMP), lead-
ing to cytochrome c release and caspase protease activation is a major
event during apoptosis. BCL-2 family members are pivotal regulators
of MOMP, but it is unknown how they regulate this process. BID, a
pro-apoptotic BCL-2 family member, plays a critical role in executing
apoptosis in the liver by initiating MOMP. Previously, mitochondrial
carrier homolog 2 (MTCH2) was demonstrated to interact with BID in
cells signaled to die. MTCH2 is a novel and previously uncharacter-
ized 33-kDa protein, which belongs to the mitochondrial carrier
family. By using a conditional knockout mouse MTCH2 was demon-
strated to be essential for BID-induced apoptosis in the liver, but its
mechanism of action remains unknown. A detailed bioinformatic
analysis was carried out to assess how closely related MTCH2 is to
other mitochondrial carriers. MTCH2 has the same structural features
and topology as other mitochondrial carriers, but it has a unique
substrate binding site, suggesting that the putative substrates differ
chemically and structurally from known carrier substrates. In
addition, MTCH2 has incomplete matrix and cytoplasmic salt bridge
networks, indicating a low energy barrier to conformational changes.
How will the substrates of MTCH2 be identified? The observation that
MTCH2 has a unique substrate binding site with well-defined
chemical features may help to narrow down substrate candidates.
In addition, MTCH2 orthologs do not exist in yeast and plants,
indicating that the substrate either does not exist or does not need to
be transported into mitochondria in these organisms. To screen for
substrate candidates the human MTCH2 was expressed in the
cytoplasmic membrane of the Gram-positive bacterium Lactococcus
lactis. The main advantage of using this system is that transport
assays for the identification of the substrate can be performed with
whole cells, as the carrier is directly accessible to the provided
substrates. Establishing the role of MTCH2 as a mitochondrial carrier
may have important implications for mitochondrial metabolism and
the regulation of MOMP by BCL-2 family members during apoptosis.
*Visiting Scientist at (2).
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Mrp antiporters catalyze secondary Na+(Li+)/H+ antiport and/or
K+/H+ antiport that is physiologically important in diverse bacteria.
Mrp is unique among antiporters in requiring all six or seven
hydrophobic gene products (MrpA to MrpG) of the mrp operon for
antiport activity. The MrpA, D and C proteins of the MrpA-B-C-D
module have sequence similarity with Complex I subunits whereas
the MrpE-F-G module is Mrp-specific [1,2]. A panel of site-direct
mutants in 28 conserved or specific motif-related amino acid residues
from an alkaliphile Mrp Na+/H+ antiporter was constructed. Each
mutant transporter was expressed in antiporter-deficient Escherichia
coli strain KNabc and the mutations were classified into 7 groups
based on assays of growth/sodium-resistance, antiport properties,
Mrp subunit levels, and formation of monomeric and dimeric Mrp
complexes that are the active forms [1]. The analyses identified
charged residues that are important for antiport activity and that are
conserved across the large Mrp subunits of the MrpA-D module,
MrpA, MrpD, as well as membrane-bound subunits (NuoL/M/N) of
complex I. These included MrpA-K223, -K299 and MrpD-K219 as well
as acidic residues that had been identified in Bacillus subtilis Mrp [3].
This study also extended evidence for a key role for MrpE of the
MrpE-F-G module. MrpE is required for normal membrane levels of
other Mrp proteins and normal complex formation. Conversely, some
mutations in the MrpA-to-D module affected membrane levels of
MrpE. Residues that are required for formation of the monomeric
form or both forms of hetero-oligomeric Mrp complexes were
identified for the first time. A mutation of Proline81 in MrpG
produced a novel Mrp that supported sodium-resistance but lacked
antiport activity. While a pair of tyrosines and a VFF motif with
proposed roles in sodium-binding were mutated without effect,
mutation of MrpA-H700 of a putative quinone binding site affected
Km values for the activity.
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Excessive iron is known to amplify ROS by Fenton and Haber–
Weiss reaction, with subsequent damage of proteins, lipids and DNA
of mitochondria. As one of the components affected by iron, cardio-
lipin, a tetra-acyl phospholipid, is crucial for oxidative phosphoryla-
tion of mitochondria. Recently, we showed that iron uptake was
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associated with ATP hydrolytic activity in mitochondria. Since the
activity of F1FOATP synthase is modulated by cardiolipin, we
supposed that the cardiolipin might as well regulate the iron uptake
in mitochondria. To study this postulation, proteoliposome recon-
stituted with iron overloaded enzyme was prepared. In the absence of
cardiolipin but with asolectin only, iron uptake was stimulated more
by ATP (1 mM) than ADP, whereas in the presence of cardiolipin, iron
uptake was augmented higher by ADP (0.1 mM) than ATP. However,
this ADP stimulation was diminished with augmenting the concen-
tration of inorganic phosphate. Interestingly proteoliposome with
iron overloaded enzyme exhibited parallel uptake of calcium and iron
by ADP in the absence of cardiolipin. However, in the presence of
cardiolipin, uptake pattern was changed as import of iron accom-
panies export of calcium and vice versa. This result suggests that
cardiolipin may support iron uptake for iron overloaded enzyme by
modulating molecular structure of enzyme.
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The M2 proton channel of influenza virus A was reconstituted into
liposomes using our improved detergent-removal methodology (see
Sindra Peterson Årsköld's poster). This yielded tight unilamellar
vesicles of reproducibly high quality and unidirectional orientation of
M2, with the N-terminal out. Using the novel, membrane-imperme-
able pH sensor Glu3 (Leiding et al., 2009, Anal. Biochem. 388: 296-
305), we monitored intravesicular pH and thus proton flux through
M2. The observed flux was amantadine-sensitive, verifying that it was
indeed channel-mediated. We present the proton flux recorded
through M2 under a number of conditions: under a pH gradient in the
absence and presence of valinomycin, under K+(in)/Na+(out)
concentration gradients at varying pH, and under K+(out)/Na+(in)
concentration gradients. We also show that while acidic reconstitu-
tion conditions inhibit M2 irreversibly, lowering the pH after
reconstitution at pH 7 has a fundamentally different effect. Our
results point towards M2 being a co-transporter rather than a pure
proton channel: it can transport Na+ along with H+, it can transport
Na+ and K+ in exchange for H+, and it can transport H+ in both
directions. While not disputing the strong preference M2 shows for
protons, our results explain how M2 acidifies the viral interior
without building up an electrical counterpotential, and unifies a
number of apparently contradictory results in the literature.
doi:10.1016/j.bbabio.2010.04.151
3P.9 Studying the mechanisms of RNA translocation
into mitochondria
T. Schirtz1, M. Vyssokikh1,2, O. Kolesnikova1,2, N. Entelis1, I. Tarassov1
1UMR 7156 CNRS—UdS, Strasbourg, France
2Moscow State University, Moscow, Russia
E-mail: tom.schirtz@etu.unistra.fr
A growing field of evidence confirms that a large number of
human diseases, such as mitochondrial encephalomyopathy, lactic
acidosis, and stroke-like episodes (MELAS) or myoclonic epilepsy
with ragged red fibers (MERRF), arise from mutations in tRNA genes
coded by the mitochondrial DNA [1]. An understanding of the fine
mechanisms of tRNA import from cytosol could help us to improve
delivery of “therapeutic” RNA molecules into mitochondria to cure
the negative effects of these mutations at the molecular level. It has
been demonstrated that the import of tRNALys into mitochondria of
the yeast Saccharomyces cervisiae needs ATP as energy source and the
electrochemical membrane potential Δψ [2] as a driving force for its
transmembrane movement. It has also been shown that this tRNALys
has to be aminoacylated in the cytosol by the lysyl-tRNA-synthetase
(KRS) and that its import requires two cytosolic targeting factors—the
enolase-2, an enzyme of the glycolytic pathway, and the cytosolic
precursor of the mitochondrial lysyl-tRNA-synthetase (preMSK) [3,4].
Little is still known about the molecular mechanisms involved in the
translocation of the tRNALys across mitochondrial membranes, and
proteins implicated in its import are not identified yet. Since import
of tRNALys requires the preMSK, their co-import through the pre-
protein import machinery may be suggested. However, analysis of
yeast strains, carrying deletions of non-essential genes coding for
proteins of the pre-protein import machinery, revealed that none of
these mutations had an effect on tRNALys import. With the help of
Northwestern analysis, combined with tandem mass spectrometry
(MALDI TOF), several proteins, among which mitochondrial porin,
TOM40, adenine nucleotide translocator, HSP60 and subunit 2 of bc1
complex were identified as potential binders of tRNALys upon its
import into mitochondria, and their possible impact on import was
studied in comparison for wild type and ΔPOR1 yeast strain.
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Intracellular vesicular transport in eukaryotic cell is composed of
three steps; selected cargo proteins are loaded into 50–100 nm
diameter membrane vesicles, cargo loaded vesicle bud from the
surface of intracellular organelles and fuse with the membrane of the
recipient organelles. Thereby, the membrane components of trans-
port vesicles and cargo proteins are transported. These transport
vesicles are coated with a protein complex called “coat protein”, their
binding is controlled by low molecular weight GTPase [1]. Coat
protein complex II (COPII) vesicles are coated with the COPII coat
proteins, namely, Sec23/24p and Sec13/31p and a low-molecular-
weight GTPase Sar1p. The formation of the COPII vesicles starts when
Sar1p, which is a low molecular weight GTPase, is converted from a
GDP form (inactive form) to a GTP form (active form) by the guanine
nucleotide exchange factor (GEF) Sec12p, which is present on the
endoplasmic reticulum. COPII vesicle formation can be reconstituted
in vitro by using these 5 protein complexes [2,3]. So, we try to
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